Skip to main content
. 2021 Feb 26;14(4):399–406. doi: 10.21053/ceo.2020.02124

Fig. 1.

Fig. 1.

Seventy-two family members of patients with definite or probable hereditary hemorrhagic telangiectasia (HHT) were genetically screened for pathogenic variants in known HHT genes (ENG and ACVRL1). Clinical and genetic analyses were performed of the genetic variant-positive and negative patients.